These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 21965636)

  • 1. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
    J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
    J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
    Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
    J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
    Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
    Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
    Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
    Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
    Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
    Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
    Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
    Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
    Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
    Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome.
    Russell IJ; Crofford LJ; Leon T; Cappelleri JC; Bushmakin AG; Whalen E; Barrett JA; Sadosky A
    Sleep Med; 2009 Jun; 10(6):604-10. PubMed ID: 19410509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.
    Siddall PJ; Cousins MJ; Otte A; Griesing T; Chambers R; Murphy TK
    Neurology; 2006 Nov; 67(10):1792-800. PubMed ID: 17130411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.
    Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M;
    Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
    Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
    Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Arnold LM; Hirsch I; Sanders P; Ellis A; Hughes B
    Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgia.
    Arnold LM; Emir B; Pauer L; Resnick M; Clair A
    Pain Med; 2015 Jan; 16(1):176-85. PubMed ID: 25529830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study.
    Arnold LM; Arsenault P; Huffman C; Patrick JL; Messig M; Chew ML; Sanin L; Scavone JM; Pauer L; Clair AG
    Curr Med Res Opin; 2014 Oct; 30(10):2069-83. PubMed ID: 24867298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the fibromyalgia impact questionnaire at baseline as a predictor for time to pain improvement in two clinical trials of pregabalin.
    Bushmakin AG; Cappelleri JC; Chandran AB; Zlateva G
    Int J Clin Pract; 2013 Jan; 67(1):52-9. PubMed ID: 23241048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.